Ardelyx, Inc. (ARDX)
3.74
-0.15
(-3.86%)
USD |
NASDAQ |
Aug 24, 16:00
3.76
+0.02
(+0.53%)
After-Hours: 20:00
Ardelyx Profit Margin (Quarterly) : -13.83% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.83% |
| March 31, 2026 | -39.80% |
| December 31, 2025 | -0.32% |
| September 30, 2025 | -0.88% |
| June 30, 2025 | -19.54% |
| March 31, 2025 | -55.51% |
| December 31, 2024 | 4.00% |
| September 30, 2024 | -0.82% |
| June 30, 2024 | -22.47% |
| March 31, 2024 | -57.62% |
| December 31, 2023 | -83.82% |
| September 30, 2023 | 11.76% |
| June 30, 2023 | -76.66% |
| March 31, 2023 | -235.5% |
| December 31, 2022 | 24.21% |
| September 30, 2022 | -459.1% |
| June 30, 2022 | -1.07K% |
| March 31, 2022 | -6.00K% |
| December 31, 2021 | -3.52K% |
| September 30, 2021 | -3.72K% |
| June 30, 2021 | -3.44K% |
| March 31, 2021 | -503.7% |
| December 31, 2020 | -1.60K% |
| September 30, 2020 | -667.5% |
| June 30, 2020 | -1.36K% |
| Date | Value |
|---|---|
| March 31, 2020 | -1.84K% |
| December 31, 2019 | -879.6% |
| September 30, 2019 | -781.2% |
| June 30, 2019 | -141.5K% |
| March 31, 2019 | |
| December 31, 2018 | -32.78K% |
| September 30, 2018 | -14.03K% |
| June 30, 2018 | -74.30K% |
| March 31, 2018 | -733.6% |
| December 31, 2017 | 24.08% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 49.64% |
| March 31, 2015 | -59.53% |
| December 31, 2014 | -62.64% |
| September 30, 2014 | 0.97% |
| June 30, 2014 | 17.66% |
| March 31, 2014 | -10.90% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| REGENXBIO, Inc. | 21.02% |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Anika Therapeutics, Inc. | 10.15% |
| Savara, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -36.72% |
| Return on Assets | -10.98% |
| Return on Invested Capital | -15.09% |
| Gross Profit Margin (Quarterly) | 94.74% |
| Operating Margin (Quarterly) | -10.28% |
| Return on Net Operating Assets | -45.94% |